Due to early data on cancer cell treatment, Caribou Biosciences' stock price fell to a record low, ultimately dropping 31%.
由于癌症细胞治疗的早期数据Caribou Biosciences股价跌至创纪录的低位最终下跌31%。
Due to early data on cancer cell treatment, Caribou Biosciences' stock price fell to a record low, ultimately dropping 31%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.